Riskpilot← Back to searchSign inGet full accessBittium Biosignals Oy
OYActiveY-tunnus 0536385-5Pioneerinkatu 6Manufacture of irradiation, electromedical and electrotherapeutic equipment · NACE 2660Est. 198497 employees
Revenue 2024
EUR 18,5M
-10% vs 2023
EBITDA margin
7.7%
+527% vs 2023
Equity ratio
9.1%
Financial strength
Net profit 2024
EUR -1,1M
+60% vs 2023
| Revenue | EUR 18,5M | -10% |
| EBITDA | EUR 1,4M | +527% |
| Net profit | EUR -1,1M | +60% |
| Total assets | EUR 20,4M | +12% |
| Equity | EUR 1,9M | -37% |
| Employees | 97 | — |
Legal name
Bittium Biosignals Oy
Y-tunnus number
0536385-5
Legal form
Osakeyhtiö
NACE code
2660 · Manufacture of irradiation, electromedical and electrotherapeutic equipment
Founded
12. tammikuuta 1984
Share capital
EUR 57 857
Employees
97 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Toimiala: Elektronisten laitteiden kehitys, valmistus, tuonti, vienti ja kauppa sekä elektroniikkaan liittyvä koulutustoiminta.
Address
Pioneerinkatu 6
Phone
+3580175817700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 420 | 26 981 | 22 095 | 20 430 | 18 479 |
| Staff expenses | −3 320 | −4 326 | −6 481 | −7 830 | −5 737 |
| EBITDA | 4 160 | 6 900 | 2 233 | −332 | 1 418 |
| Depreciation & amort. | −676 | −1 182 | −1 821 | −1 935 | −1 610 |
| EBIT | 3 483 | 5 718 | 412 | −2 266 | −192 |
| Net financials | −142 | −120 | −211 | 19 | −5 |
| Profit before tax | 502 | 719 | −999 | −2 767 | −1 107 |
| Tax | 710 | 1 220 | 300 | −0 | −0 |
| Net profit | −208 | −501 | −1 299 | −2 767 | −1 107 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 647 | 15 624 | 17 838 | 18 171 | 20 366 |
| Equity | 3 032 | 2 530 | 5 731 | 2 964 | 1 856 |
| Long-term debt | 9 | 1 | 48 | 0 | 0 |
| Short-term debt | 9 296 | 12 192 | 10 877 | 14 334 | 17 399 |
| Total debt | 9 616 | 13 094 | 12 107 | 14 334 | 17 399 |
EBITDA margin
7.7%
This company
15.8%
Market median
-51% vs market
20202024
Equity ratio
9.1%
This company
38.2%
Market median
-76% vs market
20202024
Return on equity
-59.7%
This company
18.4%
Market median
-424% vs market
20202024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20202024
Asset turnover
0.91×
This company
1.12×
Market median
+19% vs market
20202024
Debt / equity
9.97×
This company
0.62×
Market median
-1508% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NK Confidential Clerk | Confidential Clerk | 2025 |
AJ Confidential Clerk | Confidential Clerk | 2024 |
| Former (7) | ||
AJ Confidential Clerk | Confidential Clerk | 2016 – 2021 |
AJ Confidential Clerk | Confidential Clerk | 2016 – 2022 |
LK Confidential Clerk | Confidential Clerk | 2024 – 2025 |
AJ Confidential Clerk | Confidential Clerk | 2022 – 2024 |
MJ Audit | Audit | 2016 – 2019 |
AT Confidential Clerk | Confidential Clerk | 2021 – 2024 |
JP | Audit | 2019 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairperson | 2025 | |
| Board of Directors | 2024 | |
| Board of Directors | 2016 | |
| Former (4) | ||
| Board of Directors | 2016 – 2023 | |
| Chairperson | 2016 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Chairperson | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bittium Oyj
Bittium Biosignals Oy Board members of Bittium Biosignals Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arto Jaakko Remes | Confidential Clerk | 0 companies |
| Arto Juha Pietilä | Confidential Clerk | 0 companies |
| Niina Katriina Huikuri | Confidential Clerk | 0 companies |
| Laura Kauppinen | Confidential Clerk | 0 companies |
| Antti Juhani Näykki | Confidential Clerk | 0 companies |
| Markku Juhani Rönkkö | Audit | 0 companies |
| Aki Tapani Tiihonen | Confidential Clerk | 0 companies |
| Arto Juhani Niva | Confidential Clerk | 0 companies |
| Jari Petteri Karppinen | Audit | 0 companies |
| Petri Juhani Toljamo | Chairperson | 0 companies |
| Pekka Tapani Kunnari | Board of Directors | 0 companies |
| Hannu Juhani Huttunen | Chairperson | 0 companies |
| Antti Juhani Keränen | Board of Directors | 0 companies |
| Petri Tapani Hiljanen | Board of Directors | 0 companies |
| Kari Tapio Jokela | Board of Directors | 0 companies |
| Lars Johan Westermarck | Chairperson | 0 companies |